BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 2841451)

  • 1. Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
    Moroi-Fetters SE; Neff NH; Hadjiconstantinou M
    J Pharmacol Exp Ther; 1988 Aug; 246(2):553-7. PubMed ID: 2841451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C; el-Fakahany EE
    Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
    Gil DW; Wolfe BB
    J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
    Brown JH; Goldstein D; Masters SB
    Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems.
    McKinney M; Anderson D; Vella-Rountree L
    Mol Pharmacol; 1989 Jan; 35(1):39-47. PubMed ID: 2536467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
    McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
    Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the subtype of muscarinic receptor coupled to the stimulation of phosphoinositide hydrolysis in 132-1N1 human astrocytoma cells.
    Stephan CC; Sastry BV
    Cell Mol Biol (Noisy-le-grand); 1992 Nov; 38(7):701-12. PubMed ID: 1282058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation between muscarinic receptor-mediated inhibition of adenylate cyclase and autoreceptor inhibition of [3H] acetylcholine release in rat hippocampus.
    Vickroy TW; Cadman ED
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1039-44. PubMed ID: 2557410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of the muscarinic receptors mediating phosphoinositide hydrolysis in rat myometrium.
    Varol FG; Hadjiconstantinou M; Zuspan FP; Neff NH
    J Pharmacol Exp Ther; 1989 Apr; 249(1):11-5. PubMed ID: 2540309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J; Chuang DM
    J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization of muscarinic stimulated hippocampal cell firing is related to phosphoinositide hydrolysis and inhibited by lithium.
    Pontzer NJ; Crews FT
    J Pharmacol Exp Ther; 1990 Jun; 253(3):921-9. PubMed ID: 2162952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum.
    James MK; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Jan; 240(1):203-15. PubMed ID: 3806384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermic response of selective muscarinic agonists and antagonists in rat.
    Sen AP; Bhattacharya SK
    Indian J Exp Biol; 1991 Feb; 29(2):131-5. PubMed ID: 1869296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of phosphoinositide hydrolysis by muscarinic receptor activation in the rat olfactory bulb.
    Olianas MC; Onali P
    Biochem Pharmacol; 1993 Jan; 45(2):281-7. PubMed ID: 8382057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity of McN-A-343 in stimulating phosphoinositide hydrolysis mediated by M1 muscarinic receptors.
    Hu JR; el-Fakahany EE
    Mol Pharmacol; 1990 Dec; 38(6):895-903. PubMed ID: 1701216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cholinergic muscarinic receptor-stimulated phosphoinositide metabolism in brain from immature rats.
    Balduini W; Murphy SD; Costa LG
    J Pharmacol Exp Ther; 1990 May; 253(2):573-9. PubMed ID: 2160000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotropin-releasing hormone in membranes of rat frontal cortex.
    Onali P; Olianas MC
    J Pharmacol Exp Ther; 1998 Aug; 286(2):753-9. PubMed ID: 9694930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serotoninergic to muscarinic cholinergic stimulation of phosphoinositide-specific phospholipase C in rat brain cortical membranes.
    Wallace MA; Claro E
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1296-300. PubMed ID: 2175801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. I. Analysis of agonist sensitivity.
    Olianas MC; Onali P
    J Pharmacol Exp Ther; 1991 Nov; 259(2):673-9. PubMed ID: 1941616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.